⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001350078

Berkle Sheldon

Reports to the SEC for 1 company · CAMBRIDGE, MA

Transactions

6

Companies

1

Filings

3

CIK

0001350078

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2007-03-04	Altus Pharmaceuticals Inc.Stock Option (Right to buy)A Award	Director, President and CEO	AAward	+126K sh	—	—	126,250
2007-02-01	Altus Pharmaceuticals Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+9,750 sh	$3.92	+$38.2K	17,750
2007-02-01	Altus Pharmaceuticals Inc.S Sale	Director, President and CEO	SSale	−9,750 sh	$18.25	−$178K	8,000
2007-02-01	Altus Pharmaceuticals Inc.Stock Option (Right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−9,750 sh	—	—	513,443
2006-12-22	Altus Pharmaceuticals Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+8,000 sh	$3.92	+$31.4K	8,000
2006-12-22	Altus Pharmaceuticals Inc.Common Stock Option (Right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−8,000 sh	—	—	532,943

Recent filings

3

Accepted (ET)
Mar 64
Berkle Sheldon0001209191-07-015886
SEC(opens sec.gov)
Feb 24
Berkle Sheldon0001209191-07-006977
SEC(opens sec.gov)
Dec 224
Altus Pharmaceuticals Inc.0001209191-06-066654
SEC(opens sec.gov)

Companies

1

Altus Pharmaceuticals Inc.Director, President and CEO

Address

C/O ALTUS PHARMACEUTICALS INC. 125 SIDNEY STREET

CAMBRIDGE, MA, 02139